Cardiotoxicity of Cancer Therapy: Monitoring Strategies

Cardiotoxicity of Cancer Therapy: Monitoring Strategies

Cardiotoxicity of Cancer Therapy: Monitoring Strategies

Course Director(s): Joerg Herrmann, M.D.

Released On: January 15, 2016 - Length: 48:20

Add to Cart

$40-$50

Overview

slide

This tutorial will provide an overview of the monitoring strategies for patients at risk of cardiomyopathy as a consequence of cancer therapy. Algorithms for monitoring patients who are actively receiving anthracyclines or trastuzumab therapy will be reviewed as well as the surveillance of survivors following exposure to these medications or radiation therapy. These aspects are becoming an increasingly important aspect for cancer survivorship programs.    

Objectives

  • Integrate cardiac surveillance algorithms into the care of patients receiving active cancer therapy
  • Apply current monitoring recommendations for cancer survivors
  • Recognize the main modes of cardiac monitoring and their limitations

Faculty


Joerg Herrmann, M.D.
Associate Professor of Medicine
Division of Cardiovascular Diseases
Mayo Clinic, Rochester, MN

Pricing

$40 - Streaming Video

$50 - Streaming Video and DVD

Purchase Options


Choose your preferred method

50.00

DVD & Online Video

Add to Cart

40.00

Online Video Only

Add to Cart

Refer a Patient

Arizona: 866-629-6362

Florida: 800-634-1417

Minnesota: 800-533-1564


Back to top